Loading…
Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014
Legislative Progress
Introduced
September 18, 2014
Latest Action
September 18, 2014
Primary Sponsor
Orrin G. HatchRepublican(UT)
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,002 other S bills in the 113th — cohort avg 39d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (18)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2014 · fourth_quarter · Pharmacy
Issues related to prescription drug abuse, pharmacist provider status, drug pricing and drug supply chain safety.HR 3204 Drug Quality and Security Act HR 4069-Ensuring Patient Access and Effective Drug Enforcement Act of 2013 S 2862-Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014 HR 4190-Medicare Patient Access to Pharmacist Services in Medically Underserved Communities HR 4437- Generic Drug Pricing Fairness Act of 2014 HR 4709-Ensuring Patient Access and Effective Drug Enforcement Acot of 2013 S. 1493-Medicare Efficient Drug Dispensing Act of 2013
Client expense: $3,810,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2014 · fourth_quarter · Pharmacy
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion. H.R.4709 "Ensuring Patient Access and Effective Drug Enforcement Act of 2014" S.2862 "Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014"
Client expense: $338,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Alcohol and Drug Abuse
S. 2862 - "Regulatory Transparency, Patient Access and Effective Drug Enforement Act of 2014," all provisions related to changes to the registration process under the Controlled Substances Act and the report to Congress on the effects of law enforcement activities on patient access to medications.H.R. 4709 - the "Ensuring Patient Access and Effective Drug Enforcement Act of 2014," all provisions related to changes to the registration process under the Controlled Substances Act and the report to Congress on the effects of law enforcement activities on patient access to medications.
Client expense: $940,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion. H.R.4709 "Ensuring Patient Access and Effective Drug Enforcement Act of 2014" S.2862 "Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014"
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
Issues related to pharmacy benefit managers, Sustainable Growth Rate, H.R. 1024, Medication Therapy Management Act of 2013; S. 2862, the Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014, and H.R. 4709, the Ensuring Patient Access and Effective Drug Enforcement Act of 2014; and H.R. 4190, a bill to amend the Social Security Act to recognize pharmacies as providers under Medicare Part B.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
H.R. 4709 - Ensuring Patient Access and Effective Drug Enforcement Act; S. 2862-The Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014; Implementation of P.L. 113 - 54 (Drug Quality and Security Act)
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Alcohol and Drug Abuse
H.R. 4069 - Ensuring Patient Access and Effective Drug Enforcement Act of 2013 H.R. 4709 - Ensuring Patient Access and Effective Drug Enforcement Act of 2014 S. 2529 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2014 S. 2862 - Regulatory Transparency, Patient Access and Effective Drug Enforcement Act of 2014
Client expense: $460,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · fourth_quarter · Health Issues
H.R. 4069 & S. 2862 (Ensuring Patient Access and Effective Drug Enforcement Act)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
**see addendum pageImportation of prescription drugs (H.R. 3715, S. 2549) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862), Hydrocodone Rescheduling (H.R. 1285, S. 621)
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
General monitoring of issues related to transporting pharmaceuticals H.R. 4709 Ensuring Patient Access and Effective Drug Enforcement Act of 2013 S. 2862, the Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014
Client expense: $3,850,760 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
H.R.800 & S.806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R.1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.H.R.4709, S.1277, S.1657, H.R.3392, H.R.4096 & S. 2862 legislation to prevent and reduce prescription drug abuse. H.R. 4190, Provide for coverage under Medicare program of pharmicist services
Client expense: $570,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
H.R. 4299, The Improving Regulatory Transparency for New Medical Therapies Act; H.R. 3077, TELE-MED Act of 2013; H.R. 460, Patient Access to Treatments Act; S. 2862, The Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act; S.3004 The Dormant Therapies Act.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug; S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013; S. 557 Medication Therapy Empowerment Act of 2013; H.R. 1188- The Preserving Our Hometown Independent Pharmacies Act of 2013; CMS proposed and final rule on Medicare Part D; H.R. 4709- Ensuring Patient Access and Effective Drug Enforcement Act of 2014; S.2862 - Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014; H.R. 4190- To Amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services; FDAs action on and enforcement of Public Law No: 113-54; H.R.4577 - Ensuring Seniors Access to Local Pharmacies Act of 2014; H.R.4437 - Generic Drug Pricing Fairness Act; S. 1493 - Medicare Efficient Drug Dispensing Act of 2013; Generic Drug Pricing Spikes; The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; H.R..3979 Carl Levin and Howard P. Buck Mckeon National Defense Authorization Act for Fiscal Year 2015 (Tricare Provisions); Prescription Drug Abuse and Diversion; H.R. Res. 130-FY 2015 Continuing Resolution (though December 14, 2014); H.J. Res. 291- Making Further Continuing Appropriations for Fiscal Year 2015, And For Other Purposes (Until December 17, 2014); H.R.83 - FY2015 Omnibus; Consolidated and Further Continuing Appropriations Act; H.R. 4709 - Ensuring Patient Access and Effective Drug Enforcement Act of 2014;
Client expense: $420,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
2014 · fourth_quarter · Health Issues
H.R. 2575, Save American Workers Act; H.R. 4069, Ensuring Patient Access and Effective Drug Enforcement; S. 2862, Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014; Implementation issues related to the Patient Protection and Affordable Care Act (P.L. 111-148).
Client expense: $470,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · fourth_quarter · Pharmacy
Obesity product matters as well as FDA funding HR 4299 --Improving Regulatory Transparency for New Medical Therapies Act re: DEA scheduling of controlled substances S. 2862 - Transparency, Patient Access, and Effective Drug Enforcement Act of 2014 re: DEA scheduling of controlled substances
Client expense: Not reported · Firm income: $40,500
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
DEA Scheduling of Controlled Substances H.R. 4299 -- Improving Regulatory Transparency for New Medical Therapies Act S. 2862 -- Transparency, Patient Access and Effective Drug Enforcement Act of 2014
Client expense: $500,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse, (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862), Hydrocodone Rescheduling (H.R. 1285, S. 621); Counterfeit Drugs; Importation of Prescription Drugs
Client expense: $257,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · fourth_quarter · Health Issues
H.R. 4709/S. 2862: Ensuring Patient Access and Effective Drug Enforcement Act, and other legislative efforts to prevent prescription drug abuse.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Alcohol and Drug Abuse
S. 2862 - "Regulatory Transparency, Patient Access and Effective Drug Enforement Act of 2014," all provisions related to changes to the registration process under the Controlled Substances Act and the report to Congress on the effects of law enforcement activities on patient access to medications.H.R. 4709 - the "Ensuring Patient Access and Effective Drug Enforcement Act of 2014," all provisions related to changes to the registration process under the Controlled Substances Act and the report to Congress on the effects of law enforcement activities on patient access to medications.
Client expense: $890,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
H.R. 4069 & S. 2862 (Ensuring Patient Access and Effective Drug Enforcement Act)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Pharmacy
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion. H.R.4709 "Ensuring Patient Access and Effective Drug Enforcement Act of 2014" S.2862 "Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014"
Client expense: $240,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Pharmacy
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion. H.R.4709 "Ensuring Patient Access and Effective Drug Enforcement Act of 2014" S.2862 "Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014"
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Health Issues
H.R. 2575, Save American Workers Act; H.R. 4069, Ensuring Patient Access and Effective Drug Enforcement; S. 2862, Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014; Implementation issues related to the Patient Protection and Affordable Care Act (P.L. 111-148).
Client expense: $130,000 · Firm income: Not reported
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Pharmacy
H.R.800 & S.806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R.1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.H.R.4709, S.1277, S.1657, H.R.3392, H.R.4096 & S. 2862 legislation to prevent and reduce prescription drug abuse. H.R. 4190, Provide for coverage under Medicare program of pharmicist services
Client expense: $360,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Pharmacy
Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715, S. 2549)
Client expense: $361,413 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Pharmacy
Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715, S. 2549)
Client expense: $361,413 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Health Issues
The Ensuring Patient Access and Effective Drug Enforcement Act (H.R. 4069/S. 2862); Average Sales Price calculation/prompt pay discount (H.R. 800); Tax (Last in, first out)
Client expense: Not reported · Firm income: Not reported
2014 · third_quarter · Taxation/Internal Revenue Code
The Ensuring Patient Access and Effective Drug Enforcement Act (H.R. 4069/S. 2862); Average Sales Price calculation/prompt pay discount (H.R. 800); Tax (Last in, first out)
Client expense: Not reported · Firm income: Not reported
2014 · third_quarter · Pharmacy
**see addendum pageImportation of prescription drugs (H.R. 3715, S. 2549) Drug Shortages and Gray Market (H.R. 1958) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862), Hydrocodone Rescheduling (H.R. 1285, S. 621), Dextromethorphan (S. 644)
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
H.R. 4709/S. 2862: Ensuring Patient Access and Effective Drug Enforcement Act, and other legislative efforts to prevent prescription drug abuse.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Pharmacy
H.R. 4709 - Ensuring Patient Access and Effective Drug Enforcement Act; S. 2862-The Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014; H.R. 4299 - Improving Regulatory Transparency for New Medical Therapies Act; Implementation of P.L. 113 - 54 (Drug Quality and Security Act)
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
General monitoring of issues related to transporting pharmaceuticals H.R. 4709 Ensuring Patient Access and Effective Drug Enforcement Act of 2013 S. 2862, the Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014
Client expense: $3,101,780 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug; S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013; S. 557 Medication Therapy Empowerment Act of 2013; H.R. 1188- The Preserving Our Hometown Independent Pharmacies Act of 2013; CMS proposed and final rule on Medicare Part D; H.R. 4709- Ensuring Patient Access and Effective Drug Enforcement Act of 2014;S.2862 - Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014; H.R. 4190- To Amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services; FDAs action on and enforcement of Public Law No: 113-54; H.R.4577 - Ensuring Seniors Access to Local Pharmacies Act of 2014; H.R.4437 - Generic Drug Pricing Fairness Act; S. 1493 - Medicare Efficient Drug Dispensing Act of 2013; Generic Drug Pricing Spikes; The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; H.R..4435 National Defense Authorization Act for Fiscal Year 2015 (Tricare Provisions); S. 2410 National Defense Authorization Act for Fiscal Year 2015 (Tricare Provisions); Perscription Drug Abuse and Diversion; H.Con.Res 25: Establishing the budget for the United States government for Fiscal Year 2014 and setting forth appropriate budgetary levels for Fiscal Year 2015 through 2023; S.Con.Res 8: An original concurrent resolution setting forth the Congressional budget for the United States Government for Fiscal Year 2014, revising the appropriate budgetary levels for Fiscal year 2013, and setting forth the appropriate budgetary levels for Fiscal Years 2015 through 2023.
Client expense: $530,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2014 · third_quarter · Health Issues
H.R. 4299, The Improving Regulatory Transparency for New Medical Therapies Act; H.R. 3077, TELE-MED Act of 2013; H.R. 460, Patient Access to Treatments Act; S. 2862, The Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE